Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Did Slick Boink Monica? -- Ignore unavailable to you. Want to Upgrade?

To: Grainne who wrote (14350)	4/21/1998 10:55:00 PM
From: DD™	Read Replies (1) \| Respond to of 20981

JORDAN INTERN SCANDAL NEXT? DRUDGE REPORT By Matt Drudge Tue Apr 21 '98 19:27:01 PDT NY POST: WHITE HOUSE INTERN, AGE 20, TESTIFIES SHE HAD PRIVATE DINNERS WITH VERNON JORDAN A former White House intern has recently testified that she shared private lunch and dinners with Vernon Jordan, the NEW YORK POST is set to report on Wednesday. Stacey Parker, age 20 at the time, first met Jordan while interning in George Stephanopoulos' White House office. "I consider him a friend," Parker said under oath. "We've gone out to lunch, and there were two or three times we've gone out to dinner." Parker testified that she was alone with Jordan during the meals. Parker, 23, currently works as an assistant to senior White House adviser Paula Begala. The POST is set to explore the Jordan/Parker meetings, the DRUDGE REPORT has learned. DD (Drudge Double)

To: Grainne who wrote (14350)	4/22/1998 12:56:00 AM
From: LoLoLoLita	Read Replies (1) \| Respond to of 20981

>>As a physician, I am sure you are aware ... and >>most of that population is self-medicating ... >>for a host of psychological and physiological conditions, >>some of which we don't fully understand yet. Christine, Exactly! You are a tower among physicians. this from Jonathon Ott, "Pharmacophilia: The Natural Paradises," (published 1997, by Natural Products Company), p. 165: ------------------- Prior to the advent of out modern thymoleptic therapy, opium and opiates were successfully employed in treatment of depression and some data indicate that types of depression may be treated with endopioids such as the beta-endorphin, suggesting deficiencies in endopioid metabolism could figure in the aetiology of depression. More specifically, there is evidence some defect in concentration or conformation of opioid receptors underlies depression [vide: Irl Extrein et alia, "A possible opioid receptor dysfunction in some depressive disorders," Annals of the New York Academy of Sciences. 398: 113-119, 1982.] It was shown that the mixed opiate agonist/antagonist buprenorphine (Temgesic) Merck Index 12:1522] was effective in relieving some cases of depression, especially those which did not respond to conventional therapy, and for which the last-resort alternative would be electroshock, which also influences the opioid system [vide: H.M. Emrich et allii, "Possible antidepressive effects of opioids: Action of buprenorphine," Annals of the New York Academy of Sciences, 398: 108-112, 1982: vide item] J.A. Brodkin et alii "Buprenorphine treatment of refractory depression," Journal of Clinical Psychopharmacology 15:49-57, 1995.